These are meant to be indefinite medications, said Joshua Neal, M.D., chief of the MUSC Health Wellness and Human Performance Integrated Center of Clinical Excellence (ICCE) and an obesity medicine physician
A randomized phase 3b clinical trial comparing two widely used glucagon-like peptide-1 receptor agonists (GLP-1 RAs) shows that once-weekly subcutaneous semaglutide leads to substantially greater and more durable weight loss than once-daily subcutaneous liraglutide in adults with overweight or obesity who do not have diabetes
[18] [19] Sebbene la somministrazione di ALCAR sia stata spesso suggerita al posto della semplice L-carnitina, a causa di una maggiore biodisponibilit, diversi studi hanno messo in evidenza che ALCAR possa in realt avere una biodisponibilit orale minore rispetto alla forma non acetilata
Seek medical care for severe reactions Severe rash, blistering, swelling, or signs of an allergic reaction require prompt medical attention
Zvenyach also recommends keeping meticulous records
If alternative therapy is needed, caution should be exercised when considering other GLP-1 receptor agonists due to potential cross-reactivity